Vitiligo
Conditions
Interventions
Chinese traditional medicine group:Taking Chinese traditional medicine, every week 2 agent, the interval of treatment, for six consecutive months, observed after discontinuation of six months.
The placebo group:A placebo, a week 2 agent, the interval of treatment, for six consecutive months, observed after discontinuation of six months.
Sponsors
Chongqing Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1)18 years old = age =65 years old ; (2) The stability of non segmental vitiligo patients with vitiligo in plateau (2021 edition) in diagnosis and treatment of vitiligo consensus: ?VIDA to 0 points;?clinical features: a white spot in porcelain white, edge clear or pigmentation.?no isomorphic response (1 year) or higher;?Wood lamp: skin color is white, the boundary is clear, Wood light skin area or less visual area;Non segmental vitiligo vitiligo (reference 2012 global consensus conference) : including the distributing type, hair, face acromegaly and mucous membrane.Distributing type refers to the white spot 2 pieces or more, covers an area of 1 ~ 3 level;Pan hair is white spot size 4 (> 50%);Surface acromegaly type refers to the white spot is mainly limited to the head, limbs, especially in remote and facial toes around the mouth cavity, can for the development of distributed type, hair style;Mucous membrane type refers to the white spot in two or more mucous membrane, can for the development of distributed type, hair style; (3) Per patient has three white spots at least ,and the white spot restores 75 % than the initial lesions by the wood lamp; (4) Signed informed consent;
Exclusion criteria
Exclusion criteria: (1) Pregnant and lactation women; (2) For treatment of drug allergies; (3) Need to patients with long-term exposure to the sun; (4) Cannot with visitors for a long time; (5) Assessed by the doctor think that don't fit into the group of patients (complicated by severe infection, tumor, other autoimmune diseases, serious cardiovascular disease, kidney disease, etc.). (6) Refused to sign a consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| White spot activity score (VIDA);White spot area;White spot color score (VASI); | — |
Secondary
| Measure | Time frame |
|---|---|
| The quality of life score (DLQI); | — |
Countries
China
Contacts
Public ContactLin Mao
Chongqing Hospital of Traditional Chinese Medicine
Outcome results
None listed